FluGen to test latest universal flu vaccine on kids
A flu vaccine developed by Madison-based FluGen is for the first time being tested on children and teenagers in a clinical trial, according to a report from the Wisconsin State Journal. The test, which began in August, is being subsidized by a division of the National Institutes of Health.
The trial participants include 50 healthy children between the ages of 9 and 17 who will be studied at a vaccine and treatment evaluation unit at Saint Louis University, in St. Louis, Missouri, over the next year. Known as RedeeFlu, the vaccine is administered through a nasal spray.
FluGen has been working on a universal flu vaccine designed to protect against all strains of influenza in circulation.